Launch Therapeutics
USEntry
2022
Hold
4yr
Status
Active
Who owns Launch Therapeutics?
Launch Therapeutics is currently owned by Abingworth through Abingworth Clinical Co-Development Fund 2 (2021 vintage), since 2022.
Hand-verified · updated 2026-07-08
More from Abingworth Clinical Co-Development Fund 2
Other portfolio companies in the same fund.
More Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Launch Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Launch Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Launch Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue